These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The effect of chronic reserpine administrated on vanilmandelic acid excretion, blood pressure and pulse rate in normal men. Davidson MB; Mager M; Killian P; Freinkel N Am J Med Sci; 1970 Jun; 259(6):405-11. PubMed ID: 5422284 [No Abstract] [Full Text] [Related]
23. Cardiovascular actions of a new metabolite of propranolol: isopropylamine. Ishizaki T; Privitera PJ; Walle T; Gaffney TE J Pharmacol Exp Ther; 1974 Jun; 189(3):626-32. PubMed ID: 4152314 [No Abstract] [Full Text] [Related]
24. Cardiovascular effects and pharmacokinetics of the carboxylic ionophore monensin in dogs and rabbits. Fahim M; Pressman BC Life Sci; 1981 Nov; 29(19):1959-66. PubMed ID: 7311727 [No Abstract] [Full Text] [Related]
25. Effects of chronic administration of furosemide on the haemodynamics, blood volume and electrolytes in dogs. Koob R; Prasad K J Physiol (Paris); 1978; 74(1):37-43. PubMed ID: 690946 [No Abstract] [Full Text] [Related]
26. [Promotion of organ circulation by raubasine]. Dietmann K Arzneimittelforschung; 1967 Aug; 17(8):969-75. PubMed ID: 5632071 [No Abstract] [Full Text] [Related]
27. [The effect of reserpine, guanethidine and methyldopa on general and regional hemodynamics]. Iuzhakov SD; Kotliarov EV Farmakol Toksikol; 1973; 26(4):429-32. PubMed ID: 4789888 [No Abstract] [Full Text] [Related]
31. Effects of reserpine on the development of neuropsychogenic hypertension in dogs. Zeng GY; Xie SY; You SQ; Jin YC Sci Sin; 1980 Jun; 23(6):796-802. PubMed ID: 7191142 [TBL] [Abstract][Full Text] [Related]
32. [Effect of prostaglandin A1 on systemic and regional hemodynamics in dogs]. Flerov EV; Ismailov ShI Farmakol Toksikol; 1977; 40(4):407-12. PubMed ID: 902738 [TBL] [Abstract][Full Text] [Related]
33. The effects of reserpine on the cardiovascular responses to phentolamine. Hilliard CC; Bagwell EE; Daniell HB; Freeman BF Arch Int Pharmacodyn Ther; 1972 Mar; 196(1):55-63. PubMed ID: 5059369 [No Abstract] [Full Text] [Related]
34. The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant. Strosberg AM Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):200-15. PubMed ID: 10864 [TBL] [Abstract][Full Text] [Related]
35. Alteration of vasopressin tachyphylaxis by reserpine pretreatment. Nash CB Arch Int Pharmacodyn Ther; 1965 May; 155(1):90-5. PubMed ID: 5834943 [No Abstract] [Full Text] [Related]
36. Cardiovascular effects produced in cats by the chronic administration of small doses of reserpine. Withrington P; Zaimis E Cardiovasc Res; 1967 Jan; 1(1):52-62. PubMed ID: 6060161 [No Abstract] [Full Text] [Related]
37. Hemodynamic effects of vasopressin. An experimental study in normovolemic and hypovolemic anesthetized dogs. Ericsson BF Acta Chir Scand Suppl; 1971; 414():1-29. PubMed ID: 4935762 [No Abstract] [Full Text] [Related]
38. [Effect of 1-ethyl-4-(2-morpholinoethyl)-3, 3-diphenyl-2-pyrrolidinone hydrochloride hydrate (doxapram) on respiration and circulation]. Kubota T; Sasaki T; Nakazawa M Nihon Yakurigaku Zasshi; 1974 Nov; 70(6):757-66. PubMed ID: 4533748 [No Abstract] [Full Text] [Related]
39. The effect of reserpine on the metabolism of tritiated digoxin in the dog and in man. Marcus FI; Pavlovich J; Lullin M; Kapadia G J Pharmacol Exp Ther; 1968 Feb; 159(2):314-23. PubMed ID: 5638653 [No Abstract] [Full Text] [Related]
40. [Hemodynamics after intravenous administration of guanethidine, reserpine and hydrochlorothiazide]. Juchems R; Ammerschläger G Med Klin; 1967 Apr; 62(15):600-4. PubMed ID: 4871055 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]